Search for: "Astrazeneca" Results 181 - 200 of 1,244
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Mar 2024, 10:00 pm
The US District Court of Delaware recently ruled against AstraZeneca in its case challenging the constitutionality of Medicare’s new Drug Price Negotiation Program (the Program). [read post]
10 Mar 2024, 10:00 pm
The US District Court of Delaware recently ruled against AstraZeneca in its case challenging the constitutionality of Medicare’s new Drug Price Negotiation Program (the Program). [read post]
10 Mar 2024, 10:00 pm
The US District Court of Delaware recently ruled against AstraZeneca in its case challenging the constitutionality of Medicare’s new Drug Price Negotiation Program (the Program). [read post]
10 Mar 2024, 10:00 pm
The US District Court of Delaware recently ruled against AstraZeneca in its case challenging the constitutionality of Medicare’s new Drug Price Negotiation Program (the Program). [read post]
1 Mar 2009, 8:29 pm
Documents recently unsealed in a U.S. federal court case showed AstraZeneca may have known about the risk of weight gain and diabetes in 2000.At least one lawyer prosecuting the cases said internal e-mails and other documents showed AstraZeneca officials had evidence of the drug's link to weight gain but used promotions suggesting Seroquel had no effect on weight or could lead to weight loss. [read post]
17 Mar 2009, 9:32 am
At least 9,000 lawsuits have been filed alleging that AstraZeneca failed to warn patients of this risk. [read post]
27 Feb 2009, 8:47 am
Apparently, Seroquel's manufacturer saw the whole thing coming: John Tumas, an AstraZeneca publications manager, wrote in an email that AstraZeneca had "buried trials 15, 31, 56. [read post]
12 May 2017, 9:05 am by Tom Lamb
., AstraZeneca Pharmaceuticals LP, AstraZeneca LP, AstraZeneca PLC, and AstraZeneca AB (collectively, Bristol-Myers/AstraZeneca), which developed, manufactured, and marketed the drugs, failed to adequately test the drugs and warn of their risks. [read post]
12 Nov 2009, 6:19 am
Clearly a lot of off-label use was going on, encouraged by AstraZeneca. [read post]
11 Feb 2012, 7:33 pm by Dennis Crouch
By Dennis Crouch Astrazeneca v. [read post]
16 Aug 2014, 11:39 pm by Mark Summerfield
AstraZeneca AB v Apotex Pty Ltd [2014] FCAFC 99 (12 August 2014)An expanded panel of five judges of the Federal Court of Australia has held that two patents owned by AstraZeneca relating to the cholesterol-lowering drug marketed as CRESTOR (active ingredient rosuvastatin) are invalid. [read post]
26 Feb 2009, 5:21 am
And what about details of sexual relationships between Wayne Macfadden, AstraZeneca's former U.S. medical director for Seroquel, and two women who researched and wrote papers supporting the drug's safety and efficacy? [read post]
27 Apr 2010, 5:56 pm by Larry Jones
According to the allegations, AstraZeneca is fraudulently marketed Seroquel and promoted ir to patients and and doctors for unapproved uses. [read post]
26 Sep 2017, 5:20 am by Miquel Montañá
Functionality and Scope of Protection by edited by Chris Carani€ 199 The post Spain: Accord and Sandoz vs Astrazeneca, Supreme Court of Spain, First Civil Law Chamber, 334/2016, 20 May 2016 appeared first on Kluwer Patent Blog. [read post]
13 Mar 2011, 5:20 am
Last April, AstraZeneca agreed to pay $520 million for its “off label” marketing of Seroquel. [read post]
2 Dec 2011, 1:11 pm
AstraZeneca Pharmecutical (CAFC 2011-1091) precedential; Judges Rader, Linn (author), Dyk AstraZeneca moved for summary judgment of invalidity under 35 U.S.C. [read post]